Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH): Results From the Phase 2 TORREY Trial

被引：0

作者：

Frantz, R. P. ^{[1
]}

McLaughlin, V. V. ^{[2
]}

Sahay, S. ^{[3
]}

Subias, P. Escribano ^{[4
]}

Zolty, R. L. ^{[5
]}

Benza, R. L. ^{[6
]}

Channick, R. N. ^{[7
]}

Chin, K. M. ^{[8
]}

Hemnes, A. R. ^{[9
]}

Howard, L. S. ^{[10
]}

Sitbon, O. ^{[11
]}

Vachiery, J. ^{[12
]}

Zamanian, R. T. ^{[13
]}

Cravets, M. ^{[14
]}

Roscigno, R. F. ^{[15
]}

Mottola, D. ^{[15
]}

Elman, E. ^{[16
]}

Parsley, E. ^{[15
]}

Aranda, R. ^{[17
]}

Zisman, L. S. ^{[15
]}

Ghofrani, H. ^{[18
]}

机构：

[1] Mayo Clin, Cardiovasc Med, Rochester, MN USA

[2] Univ Michigan, Cardiovasc Dis, Internal Med, Ann Arbor, MI USA

[3] Houston Methodist Hosp Weill Cornell Med, Div Pulm Crit Care & Sleep Med, Houston, TX USA

[4] Univ Complutense, Univ Hosp Octubre 12, Cardiol, Madrid, Spain

[5] Univ Nebraska Med Ctr, Internal Med, Omaha, NE USA

[6] Ohio State Univ, Wexner Med Ctr, Div Cardiovasc Dis, Columbus, OH USA

[7] UCLA Med Ctr, Pulmonol, Crit Care Med, Los Angeles, CA USA

[8] UT Southwestern Med Ctr, Internal Med, Dallas, TX USA

[9] Vanderbilt Univ, Dept Med, Nashville, TN USA

[10] Imperial Coll Healthcare NHS Trust, Cardiol, London, England

[11] Univ Paris Saclay, Hop Bicetre, Serv Pneumol, Le Kremlin Bicetre, France

[12] HUB Hop Erasme, Cardiol, Brussels, Belgium

[13] Stanford Univ, Sch Med, Pulm & Crit Care Med, Stanford, CA USA

[14] Gossamer Bio Inc, Biometr, San Diego, CA USA

[15] Gossamer Bio Inc, Clin Dev, San Diego, CA USA

[16] Gossamer Bio Inc, Clin Operat, San Diego, CA USA

[17] Gossamer Bio Inc, Clin Execut, San Diego, CA USA

[18] Justus Liebig Univ Giessen, Dept Internal Med, Giessen, Germany

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A6726

引用

页数：2

共 50 条

[31] PULSAR open-label extension: interim results from a phase 2 study of the efficacy and safety of sotatercept when added to standard of care for the treatment of pulmonary arterial hypertension (PAH)
Badesch, David
Gibbs, Simon
Gomberg-Maitland, Mardi
Hoeper, Marius
Mclaughlin, Vallerie
Preston, Ioana
Souza, Rogerio
Waxman, Aaron
Manimaran, Solaiappan
Barnes, Jennifer
Pena, Janethe De Oliveira
Humbert, Marc
Hoeper, Marius M.
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[32] Regional Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension (PAH)
Winkler, T.
Kohli, P.
Kelly, V. J.
Kehl, E. G.
Kone, M. T.
Hibbert, K.
Rodriguez-Lopez, J. M.
Systrom, D. M.
Waxman, A. B.
Venegas, J. G.
Channick, R. N.
Harris, R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[33] COST-EFFECTIVENESS OF SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN GREECE
Solakidi, A.
Tzanetakos, C.
Beaudet, A.
Zervoudaki, A.
Lamprou, C.
Maniadakis, N.
VALUE IN HEALTH, 2017, 20 (09) : A645 - A645
[34] Treatment of pulmonary arterial hypertension (PAH): Recommendations of the Cologne Consensus Conference 2010
Ghofrani, H. A.
Distler, O.
Gerhardt, F.
Gorenflo, M.
Gruenig, E.
Haefell, W. E.
Held, M.
Hoeper, M. M.
Kaehler, C.-M.
Kaemmerer, H.
Klose, H.
Koellner, V.
Kopp, B.
Mebus, S.
Meyer, A.
Miera, O.
Pittrow, D.
Riemekasten, G.
Rosenkranz, S.
Schranz, D.
Voswinckel, R.
Olschewski, H.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 : S87 - S101
[35] BUDGET-IMPACT OF SELEXIPAG FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) IN GREECE
Solakidi, A.
Tzanetakos, C.
Bilir, S. P.
Beaudet, A.
Zervoudaki, A.
Lamprou, C.
Maniadakis, N.
VALUE IN HEALTH, 2017, 20 (09) : A641 - A642
[36] The Treatment of Congenital Heart Disease Associated Pulmonary Arterial Hypertension (PAH) with Sildenafil
Crackett, R. M.
Foggo, B. A.
Day, M. B.
Small, T.
Mackay, L. S.
Fisher, A. J.
Lordan, J. L.
MacGowan, G.
Corris, P. A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[37] NT-proBNP in monitoring of treatment in patients with pulmonary arterial hypertension (PAH)
Fijalkowska, A.
Kurzyna, M.
Florczyk, M.
Szewczyk, G.
Burakowski, J.
Kober, J.
Szturmowicz, M.
Torbicki, A.
EUROPEAN HEART JOURNAL, 2006, 27 : 619 - 619
[38] Modern Treatment Patterns in Incident Pulmonary Arterial Hypertension (PAH) Patients: RealWorld Data From the Pulmonary Hypertension Association (PHA) Registry
Paoli, Carly J.
Kime, Noah
Williams, Kayleen
Gomez-Rendon, Gabriela
Tonelli, Adriano
Cajigas, Hector
Mathai, Stephen
Khan, Sarah L.
Sahay, Sandeep
CIRCULATION, 2023, 148
[39] Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)
Sitbon, Olivier
Channick, Richard
Delcroix, Marion
Galie, Nazzareno
Ghofrani, Hossein-Ardeschir
Jansa, Pavel
Le Brun, Franck-Olivier
Mehta, Sanjay
Perchenet, Loic
Pulido, Tomas
Sastry, B. K. S.
Souza, Rogerio
Torbicki, Adam
Rubin, Lewis
Simonneau, Gerald
EUROPEAN RESPIRATORY JOURNAL, 2013, 42
[40] Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH)
Rashid, Jahidur
Patel, Brijeshkumar
Nozik-Grayck, Eva
McMurtry, Ivan F.
Stenmark, Kurt R.
Ahsan, Fakhrul
JOURNAL OF CONTROLLED RELEASE, 2017, 250 : 96 - 106

← 1 2 3 4 5 →